Riggs Asset Managment Co. Inc. - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 295 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
Riggs Asset Managment Co. Inc. ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$3,419
-1.5%
2210.0%0.00%0.0%
Q2 2023$3,472
-4.7%
2210.0%0.00%0.0%
Q1 2023$3,643
+5.7%
2210.0%0.00%0.0%
Q4 2022$3,448
+14.9%
2210.0%0.00%0.0%
Q3 2022$3,0000.0%2210.0%0.00%0.0%
Q2 2022$3,0000.0%2210.0%0.00%0.0%
Q1 2022$3,0000.0%2210.0%0.00%0.0%
Q4 2021$3,000
-25.0%
2210.0%0.00%0.0%
Q3 2021$4,0000.0%2210.0%0.00%0.0%
Q2 2021$4,0000.0%2210.0%0.00%0.0%
Q1 2021$4,0000.0%2210.0%0.00%0.0%
Q4 2020$4,000
+33.3%
2210.0%0.00%0.0%
Q3 2020$3,0000.0%2210.0%0.00%0.0%
Q2 2020$3,0000.0%2210.0%0.00%
-50.0%
Q1 2020$3,000
-25.0%
2210.0%0.00%0.0%
Q4 2019$4,000
+33.3%
2210.0%0.00%0.0%
Q3 2019$3,000
-25.0%
2210.0%0.00%0.0%
Q2 2019$4,0000.0%2210.0%0.00%
-33.3%
Q1 2019$4,0002210.00%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q4 2021
NameSharesValueWeighting ↓
Glenview Capital Management 16,104,222$294,063,0004.98%
GMT CAPITAL CORP 2,468,695$45,078,0003.31%
MANAGED ASSET PORTFOLIOS, LLC 1,065,756$19,461,0003.13%
Blackcrane Capital, LLC 14,571$1,723,0002.72%
BFAM Partners (Cayman) Ltd 328,690$6,002,0002.36%
Paulson & Co. 4,727,415$86,323,0001.98%
Mondrian Investment Partners LTD 3,510,404$59,677,0001.28%
Lumbard & Kellner, LLC 135,550$2,264,0000.80%
DAVIDSON INVESTMENT ADVISORS 500,203$9,134,0000.78%
TFG Asset Management GP Ltd 589,390$10,762,0000.77%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders